Literature DB >> 14531381

Mild severe acute respiratory syndrome.

Gang Li, Zhixin Zhao, Lubiao Chen, Yihua Zhou.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 14531381      PMCID: PMC3016760          DOI: 10.3201/eid0909.030461

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Severe acute respiratory syndrome (SARS) is a recently recognized infectious disease caused by a novel human coronavirus (SARS-CoV) (). The first case of SARS, diagnosed as communicable atypical pneumonia, occurred in Guangdong Province, China, in November 2002. Thousands of patients with SARS have been reported in over 30 countries and districts since February 2003. SARS is clinically characterized by fever, dry cough, myalgia, dyspnea, lymphopenia, and abnormal chest radiograph results (–). According to the World Health Organization (WHO) (), the criteria to define a suspected case of SARS include fever (>38°C), respiratory symptoms, and possible exposure during 10 days before the onset of symptoms; a probable case is defined as a suspected case with chest radiographic findings of pneumonia and other positive evidence. Although most reported patients with SARS met the WHO criteria, we found two SARS case-patients who did not exhibit typical clinical features. Case 1 was in a 28-year-old physician. He had close contact with three SARS patients on February 1, 2003. After 10 days, he had mild myalgia and malaise with a fever of 37.3°C. He had no cough and no other symptoms. Leukocyte and lymphocyte counts were normal. The chest radiograph showed no abnormalities. He did not receive any treatment except rest at home. His symptoms disappeared after 2 days. He completely recovered and returned to work 4 days after onset of symptoms. After 12 weeks, his serum was positive for immunoglobulin (Ig) G against SARS-CoV in an indirect enzyme-linked immunosorbent assay (ELISA) with inactivated intact SARS-CoV as the coated antigen. Case 2 was in a 13-year-old boy whose mother had been confirmed to have SARS on February 4, 2003. Fever developed in the boy 20 days after his mother’s onset of the disease. He did not come into contact with other confirmed SARS patients during this period. He had a mild headache and diarrhea with a fever from 37.2°C to 37.8°C for 3 days. No other symptoms and signs developed, and a chest radiograph showed no abnormalities. He completely recovered after 5 days. After 12 weeks, his serum was positive for IgG against SARS-CoV, detected with an ELISA. In both case-patients, SARS had been initially excluded in spite of their close contacts with SARS patients because their symptoms could be explained as a common cold, and no specific diagnostic approaches were considered when they were sick since the causative agent of SARS was not identified until March 2003 (). However, their serum specimens were positive for IgG against SARS-CoV by ELISA. Those results strongly indicate that both patients had been infected with SARS-CoV, although their signs and symptoms did not meet the criteria for the SARS case definition. Mild SARS-CoV infection may not easily be defined clinically, and such patients may potentially spread the disease if they are not isolated.
  4 in total

1.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

2.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

3.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

4.  A multicentre collaboration to investigate the cause of severe acute respiratory syndrome.

Authors: 
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

  4 in total
  13 in total

1.  SARS transmission in Vietnam outside of the health-care setting.

Authors:  P A Tuan; P Horby; P N Dinh; L T Q Mai; M Zambon; J Shah; V Q Huy; S Bloom; R Gopal; J Comer; A Plant
Journal:  Epidemiol Infect       Date:  2006-07-26       Impact factor: 2.451

2.  Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection.

Authors:  Xiaohui Zhu; Yan Wang; Hongxing Zhang; Xuan Liu; Ting Chen; Ruifu Yang; Yuling Shi; Wuchun Cao; Ping Li; Qingjun Ma; Yun Zhai; Fuchu He; Gangqiao Zhou; Cheng Cao
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

3.  SARS antibody test for serosurveillance.

Authors:  Po-Ren Hsueh; Chuan-Liang Kao; Chun-Nan Lee; Li-Kuan Chen; Mei-Shang Ho; Charles Sia; Xin De Fang; Shugene Lynn; Tseng Yyuan Chang; Shi Kau Liu; Alan M Walfield; Chang Yi Wang
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

Review 4.  Entry screening for infectious diseases in humans.

Authors:  Linda A Selvey; Catarina Antão; Robert Hall
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

5.  SARS exposure and emergency department workers.

Authors:  Wei-Tien Chang; Chuan-Liang Kao; Ming-Ya Chung; Shyr-Chyr Chen; Shou-Ju Lin; Wen-Chu Chiang; Shey-Ying Chen; Chan-Ping Su; Po-Ren Hsueh; Wen-Jone Chen; Pei-Jer Chen; Pan-Chyr Yang
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

Review 6.  Certainties and uncertainties facing emerging respiratory infectious diseases: lessons from SARS.

Authors:  Yee-Chun Chen; Shan-Chwen Chang; Keh-Sung Tsai; Fang-Yue Lin
Journal:  J Formos Med Assoc       Date:  2008-06       Impact factor: 3.282

7.  Interpreting diagnostic studies in SARS--defining the reference.

Authors:  John Beigel
Journal:  Clin Immunol       Date:  2004-11       Impact factor: 3.969

8.  Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers.

Authors:  J W Tang; R C W Chan
Journal:  Curr Anaesth Crit Care       Date:  2004-06-26

9.  Mild illness associated with severe acute respiratory syndrome coronavirus infection: lessons from a prospective seroepidemiologic study of health-care workers in a teaching hospital in Singapore.

Authors:  Khek Y Ho; Kamaljit S Singh; Abdulrazaq G Habib; Benjamin K Ong; Tow K Lim; Eng E Ooi; Bijon K Sil; Ai-Ee Ling; Xin L Bai; Paul A Tambyah
Journal:  J Infect Dis       Date:  2004-01-30       Impact factor: 5.226

10.  [Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert].

Authors:  L Cibrelus; V Nöel; J Emmanuelli; G Breton; P Longuet; B Rigolli; C Leport; J-L Vildé
Journal:  Med Mal Infect       Date:  2007-11-07       Impact factor: 2.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.